Incyte
INCY
#1110
Rank
NZ$34.83 B
Marketcap
NZ$177.46
Share price
2.05%
Change (1 day)
36.48%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2025 (TTM): NZ$2.71 Billion

According to Incyte's latest financial reports the company's current earnings are NZ$4.81 Billion. In 2024 the company made an earning of NZ$0.54 Billion a decrease over its 2023 earnings that were of NZ$1.44 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$2.71 B395.78%
2024 NZ$0.54 B-62.04%
2023 NZ$1.44 B57.66%
2022 NZ$0.91 B-7.24%
2021 NZ$0.98 B-345.65%
2020 -NZ$0.41 Billion-147.7%
2019 NZ$0.84 B322.02%
2018 NZ$0.19 B-136.94%
2017 -NZ$0.55 Billion-390.76%
2016 NZ$0.18 B1322%
2015 NZ$13.07 M-115.56%
2014 -NZ$84.04 Million-41.4%
2013 -NZ$0.15 Billion87.67%
2012 -NZ$76.42 Million-74.9%
2011 -NZ$0.31 Billion843.59%
2010 -NZ$32.26 Million-88.68%
2009 -NZ$0.29 Billion1.37%
2008 -NZ$0.29 Billion86.16%
2007 -NZ$0.16 Billion17.64%
2006 -NZ$0.13 Billion-28.62%
2005 -NZ$0.18 Billion-36.1%
2004 -NZ$0.29 Billion-2.03%
2003 -NZ$0.29 Billion22.26%
2002 -NZ$0.24 Billion-27.39%
2001 -NZ$0.33 Billion198.72%
2000 -NZ$0.11 Billion132.2%
1999 -NZ$46.66 Million-556.86%
1998 NZ$10.21 M-37.23%
1997 NZ$16.27 M-259.32%
1996 -NZ$10.22 Million-45.87%
1995 -NZ$18.87 Million-9.17%
1994 -NZ$20.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$14.27 B 419.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.11 B-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.95 B 1,316.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.51 B 646.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-NZ$79.5 Million-102.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-NZ$96.16 Million-103.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.42 B 933.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
-NZ$50.27 Million-101.83%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-NZ$0.12 Billion-104.36%๐Ÿ‡บ๐Ÿ‡ธ USA